Outcomes | Associations at baselinea | Associations at follow-upb | ||
---|---|---|---|---|
Cardiorespiratory/mental/arthritis (n = 220) (b, SE) | Metabolic/stroke (n = 1060) (b, SE) | Cardiorespiratory/mental/arthritis (n = 220) (b, SE) | Metabolic/strokec (n = 1060) (b, SE) | |
Verbal fluency | −0.78 (0.50) | −0.17 (0.28) | −0.78 (0.55) | −0.78 (0.30)** |
Verbal memory | −1.39 (0.44)** | −0.76 (0.25)** | −0.87 (0.53) | −0.12 (0.29) |
Disability (WHODAS) | 22.31 (1.10)*** | 10.08 (0.61)*** | 4.29 (1.38) | 0.18 (0.75) |
Quality of life | −13.59 (0.99)*** | −6.85 (0.55)*** | −5.49 (1.21)*** | −1.75 (0.66)** |
N° medical visits last 12 months | 0.76 (0.10)*** | 0.54 (0.07)*** | 0.46 (0.15)** | 0.22 (0.11)* |
Cardiorespiratory/mental/arthritis (OR, 95%CI) | Metabolic/stroke (OR, 95%CI) | Cardiorespiratory/mental/arthritis (OR, 95%CI) | Metabolic/stroke (OR, 95%CI) | |
Limitations in ADLs (yes/no) | 7.97 (5.41–11.73)*** | 4.13 (3.07–5.54)*** | 4.05 (2.65–6.18)*** | 2.11 (1.64–2.72)*** |
Limitations in IADLs (yes/no) | 11.42 (8.04–16.22)*** | 4.47 (3.45–5.80)*** | 2.17 (1.32–3.55)** | 1.63 (1.17–2.29)** |
Hospital admission last 12 months (yes/no) | 3.77 (2.79–5.10)*** | 1.97 (1.63–2.38)*** | 1.88 (1.16–3.04)* | 1.53 (1.10–2.12)* |